These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 32731904

  • 1. Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose-response meta-analysis.
    Farhangi MA, Vajdi M, Asghari-Jafarabadi M.
    Nutr J; 2020 Jul 30; 19(1):76. PubMed ID: 32731904
    [Abstract] [Full Text] [Related]

  • 2. Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis.
    Dehghan P, Farhangi MA, Nikniaz L, Nikniaz Z, Asghari-Jafarabadi M.
    Obes Rev; 2020 May 30; 21(5):e12993. PubMed ID: 32017391
    [Abstract] [Full Text] [Related]

  • 3. Novel findings of the association between gut microbiota-derived metabolite trimethylamine N-oxide and inflammation: results from a systematic review and dose-response meta-analysis.
    Farhangi MA, Vajdi M.
    Crit Rev Food Sci Nutr; 2020 May 30; 60(16):2801-2823. PubMed ID: 32462890
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gut microbiota-associated trimethylamine N-oxide and increased cardiometabolic risk in adults: a systematic review and dose-response meta-analysis.
    Abbasalizad Farhangi M, Vajdi M.
    Nutr Rev; 2021 Aug 09; 79(9):1022-1042. PubMed ID: 33270896
    [Abstract] [Full Text] [Related]

  • 7. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.
    Zhuang R, Ge X, Han L, Yu P, Gong X, Meng Q, Zhang Y, Fan H, Zheng L, Liu Z, Zhou X.
    Obes Rev; 2019 Jun 09; 20(6):883-894. PubMed ID: 30868721
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG, Sannino A, Toscano E, Giugliano G, Gargiulo G, Franzone A, Trimarco B, Esposito G, Perrino C.
    Eur Heart J; 2017 Oct 14; 38(39):2948-2956. PubMed ID: 29020409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients.
    Nie J, Xie L, Zhao BX, Li Y, Qiu B, Zhu F, Li GF, He M, Wang Y, Wang B, Liu S, Zhang H, Guo H, Cai Y, Huo Y, Hou FF, Xu X, Qin X.
    Stroke; 2018 Sep 14; 49(9):2021-2028. PubMed ID: 30354996
    [Abstract] [Full Text] [Related]

  • 14. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
    Li Y, Lu H, Guo J, Zhang M, Zheng H, Liu Y, Liu W.
    Ann Med; 2023 Dec 14; 55(1):2215542. PubMed ID: 37246850
    [Abstract] [Full Text] [Related]

  • 15. Impact of probiotic supplementation on trimethylamine N-oxide (TMAO) in humans: A systematic review and meta-analysis of randomized controlled trials.
    Sohouli MH, Ozovanu OD, Fatahi S, Hekmatdoost A.
    Clin Nutr ESPEN; 2022 Aug 14; 50():56-62. PubMed ID: 35871952
    [Abstract] [Full Text] [Related]

  • 16. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis.
    Han JM, Guo L, Chen XH, Xie Q, Song XY, Ma YL.
    Medicine (Baltimore); 2024 Jan 05; 103(1):e36784. PubMed ID: 38181288
    [Abstract] [Full Text] [Related]

  • 17. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Räber L, Windecker S, Rodondi N, Nanchen D, Muller O, Miranda MX, Matter CM, Wu Y, Li L, Wang Z, Alamri HS, Gogonea V, Chung YM, Tang WH, Hazen SL, Lüscher TF.
    Eur Heart J; 2017 Mar 14; 38(11):814-824. PubMed ID: 28077467
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.